Bjorn B. Thaler - Dec 20, 2022 Form 4 Insider Report for 1Life Healthcare Inc (ONEM)

Role: Chief Financial Officer
Signature: /s/ Ivy Tseng, Attorney-in-Fact for Bjorn B. Thaler
Stock symbol: ONEM
Transactions as of: Dec 20, 2022
Transactions value $: -$102,238
Form type: 4
Date filed: 12/21/2022, 04:55 PM
Previous filing: Dec 5, 2022
Next filing: Jan 5, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ONEM	Common Stock	Sale	-$102K	-6.12K	-30.84%	$16.72	13.7K	Dec 20, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan and were conducted by the reporting person for tax and estate planning purposes. The reporting person has adopted Rule 10b5-1 plans in the past and has adopted this Rule 10b5-1 plan in the ordinary course. The trading plans and their parameters do not reflect the reporting person's views on the closing of the pending, previously announced, merger or the prospects of the Company's business after the closing.
F2	This transaction was executed in multiple trades at prices ranging from $16.70 to $16.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Content

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan and were conducted by the reporting person for tax and estate planning purposes. The reporting person has adopted Rule 10b5-1 plans in the past and has adopted this Rule 10b5-1 plan in the ordinary course. The trading plans and their parameters do not reflect the reporting person's views on the closing of the pending, previously announced, merger or the prospects of the Company's business after the closing.

This transaction was executed in multiple trades at prices ranging from $16.70 to $16.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.